Reaction
Eosinophilic Myocarditis reporting signals
As of the last recalculation, Eosinophilic Myocarditis appears in 721 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is GOSERELIN (PRR 117.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Goserelin | 51 | 117.9 | 118.4 |
| Ciclesonide | 51 | 116.2 | 116.7 |
| Minocycline | 41 | 107.6 | 108.0 |
| Bicalutamide | 50 | 101.7 | 102.0 |
| Sodium Bicarbonate | 44 | 58.1 | 58.2 |
| Sodium Bicarbonate Injection, | 44 | 58.1 | 58.2 |
| Salmeterol Xinafoate | 11 | 37.4 | 37.4 |
| Calcium Gluconate | 14 | 34.2 | 34.2 |
| Rifampicin | 11 | 31.9 | 31.9 |
| Lamotirigine | 69 | 30.6 | 30.7 |
| Lamotrigine Extended-Release | 69 | 30.6 | 30.7 |
| Lamotrigine Chewable Dispersible | 69 | 30.6 | 30.7 |
| Cefazolin Sodium | 11 | 26.7 | 26.8 |
| Fluticasone Propionate And Salmeterol Xinafoate | 49 | 25.2 | 25.2 |
| Aripiprazole Oral | 33 | 24.1 | 24.1 |
| Aripiprazole Orally Disintegrating | 33 | 24.1 | 24.1 |
| Cefazolin | 7 | 22.4 | 22.4 |
| Daspone | 7 | 20.9 | 21.0 |
| Dapsone Gel, 5% | 7 | 20.9 | 20.9 |
| Glimepiride | 27 | 20.7 | 20.8 |
| Oxazepam | 15 | 20.5 | 20.6 |
| Mepolizumab | 32 | 19.4 | 19.4 |
| Dapsone | 7 | 19.1 | 19.1 |
| Pyrazinamide | 5 | 15.5 | 15.5 |
| Empagliflozin | 29 | 12.9 | 12.9 |
| Benralizumab | 6 | 8.7 | 8.7 |